These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19778319)

  • 1. Economical impact of plasma fractionation project in Iran on affordability of plasma-derived medicines.
    Cheraghali AM; Aboofazeli R
    Transfus Med; 2009 Dec; 19(6):363-8. PubMed ID: 19778319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Norwegian Plasma Fractionation Project--a 12 year clinical and economic success story.
    Flesland O; Seghatchian J; Solheim BG
    Transfus Apher Sci; 2003 Feb; 28(1):93-100. PubMed ID: 12620274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience.
    Cheraghali AM; Abolghasemi H
    Haemophilia; 2009 Mar; 15(2):487-93. PubMed ID: 19347989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability of blood components and plasma derived medicines in Iran.
    Cheraghali AM
    Transfus Apher Sci; 2007 Aug; 37(1):3-7. PubMed ID: 17707696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving availability and affordability of plasma-derived medicines.
    Cheraghali AM; Abolghasemi H
    Biologicals; 2010 Jan; 38(1):81-6. PubMed ID: 20137973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma fractionation in blood transfusion service.
    Haskó F; Salamon M; Bartha K; Dobó P
    Dev Biol Stand; 1987; 67():39-48. PubMed ID: 3111912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of Iran national plasma contract fractionation program.
    Cheraghali AM
    Daru; 2012 Oct; 20(1):63. PubMed ID: 23351278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dynamics of contract plasma fractionation.
    Farrugia A; Scaramuccia D
    Biologicals; 2017 Mar; 46():159-167. PubMed ID: 28236560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma fractionation in the world: current status].
    Burnouf T
    Transfus Clin Biol; 2007 May; 14(1):41-50. PubMed ID: 17499539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surprising decline in Iran's growth rates.
    Roudi F
    Popul Today; 1997 Nov; 25(11):4. PubMed ID: 12321257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A successful experience of the Iranian blood transfusion organization in improving accessibility and affordability of plasma derived medicine.
    Chegini A; Torab SA; Pourfatollah AA
    Transfus Apher Sci; 2017 Feb; 56(1):12-16. PubMed ID: 28214180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of blood fractionation in the United States.
    Sgouris JT
    Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
    [No Abstract]   [Full Text] [Related]  

  • 13. Injectable diclofenac: a painful shot into Iran's health system.
    Cheraghali AM
    Soc Sci Med; 2006 Sep; 63(6):1597-601. PubMed ID: 16782253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of national blood safety profile: effect of contract fractionation of plasma in resource limited countries, the Moroccan experience.
    Boulahdid S; Benahadi A; Adouani B; Laouina A; Mehdaoui FE; Mokhtari A; Soulaymani A; Hajjout K; Alami R
    Haemophilia; 2014 Sep; 20(5):e359-62. PubMed ID: 25039933
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma exchange donation of cryoprecipitate after DDAVP stimulation: an alternative source of factor VIII.
    McLeod BC; Scott JP
    Prog Clin Biol Res; 1990; 324():189-98. PubMed ID: 2106687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionation of plasma with polyethylene glycol.
    Polson A; Ruiz-Bravo C
    Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005
    [No Abstract]   [Full Text] [Related]  

  • 17. [Collection and utilization of plasma in Austria: on the way to national self-sufficiency].
    Bergmann H; Lukas M; Prusa P
    Beitr Infusionsther Transfusionsmed; 1996; 33():103-10. PubMed ID: 8974681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality control of recovered plasma for fractionation: an extensive Italian study.
    Grazzini G; Rossi G; Rafanelli D; Gambelli D; Farina C; Mori F; Zucchelli P; Marchiori G; Breda A; Liumbruno GM
    Transfusion; 2008 Jul; 48(7):1459-68. PubMed ID: 18435675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, purification and virus inactivation of intravenous immunoglobulin from human plasma.
    Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Banazadeh S
    Hum Antibodies; 2010; 19(1):1-6. PubMed ID: 20555125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protein therapies: current and future perspectives.
    Farrugia A; Robert P
    Best Pract Res Clin Haematol; 2006; 19(1):243-58. PubMed ID: 16377552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.